DAVID KUNTIN

Current Organisation: MESENBIO LIMITED
(some projects in the list below may not be associated with this organisation)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£968,860

Jan 24 - Jun 26

Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis

Innovate UK award to MESENBIO LIMITED and DAVID KUNTIN

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}